Suvretta Capital Management »

Mineralys Therapeutics shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $81M 2.1M 37.92
2025-06-30 $24M 1.7M 13.53
2025-03-31 $27M 1.7M 15.88

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
BlackRock
Vanguard Group
Caligan Partners
Capital Research and Management Company - Division 3
Citadel Advisors
Suvretta Capital Management
Sr One Capital Management
FMR
Franklin Resources
Point72 Asset Management
Laurion Capital Management
Farallon Capital Management

View all funds holding Mineralys Therapeutics